International Stem Cell Corp. (ISCO) Makes Major Scientific Strides in 2012
The recent conference call by International Stem Cell Corp., covering sales and other financial data for the 4th quarter and full year for 2012, provided important insights into the prior year’s scientific accomplishments. In particular, the company made significant progress with their Parkinson’s program, progress which will now be accelerated with the addition of Dr. Evan Snyder, a renowned neurobiologist and head of the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee, as a non-compensated member of the company’s Board of Advisors. Dr. Snyder’s help in navigating the complex FDA approval process should help greatly in moving the program into…